AMGN : Summary for Amgen Inc. - Yahoo Finance

U.S. Markets open in 1 min.

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
164.910.00 (0.00%)
At close: 4:00PM EDT

164.55 -0.36 (-0.22%)
Pre-Market: 9:28AM EDT

People also watch
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close164.91
Open0.00
Bid163.60 x 100
Ask165.39 x 100
Day's Range0.00 - 0.00
52 Week Range
Volume25
Avg. Volume4,012,480
Market Cap121.45B
Beta1.76
PE Ratio (TTM)16.10
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.78%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire30 minutes ago

    Amgen Awards Three Golden Tickets for LabCentral Residency

    CAMBRIDGE, Mass., March 28, 2017 /PRNewswire/ -- Amgen (AMGN) and LabCentral announced that Cocoon Biotech, Torus Therapeutics, and Holobiome are the winners of Golden Ticket awards. Sponsored by Amgen, the Golden Ticket awards underwrite the cost of a lab bench for a scientist from each organization to reside in LabCentral's open lab for one year. LabCentral is an innovative, shared laboratory space designed as a launchpad for premier high impact life-sciences and biotech startups.

  • GuruFocus.com16 hours ago

    Amgen's Humira Biosimilar Approved in Europe

    The treatment has already been approved in the US

  • 24/7 Wall St.23 hours ago

    Short Interest Pulls Back in Major Biotechs

    The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.